Detalles de la búsqueda
1.
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Strahlenther Onkol
; 199(10): 901-909, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256301
2.
Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.
Head Neck
; 44(11): 2452-2464, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35875934
3.
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.
Cancer Biol Med
; 17(1): 208-217, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32296588
4.
Immune gene expression in head and neck squamous cell carcinoma patients.
Eur J Cancer
; 121: 210-223, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31593831
5.
Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.
Am J Clin Oncol
; 40(3): 250-255, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028351
6.
Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.
Cancer Treat Rev
; 50: 240-246, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27768919
7.
Early assessment of metabolic response by 18F-FDG PET during concomitant radiochemotherapy of non-small cell lung carcinoma is associated with survival: a retrospective single-center study.
Clin Nucl Med
; 40(4): e215-21, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25546211
Resultados
1 -
7
de 7
1
Próxima >
>>